Cited by 246SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

The DOI matches its Crossref record; 32 of the 37 references it cites were found in a registry or an index.

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections

Open access

Taquet, Maxime, Dercon, Quentin, Harrison, Paul J.·2022·Brain, Behavior, and Immunity

DOI 10.1016/j.bbi.2022.04.013PMC PMC9013695

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Vaccination has proven effective against infection with SARS-CoV-2, as well as death and hospitalisation following COVID-19 illness. However, little is known about the effect of vaccination on other acute and post-acute outcomes of COVID-19. Data were obtained from the TriNetX electronic health records network (over 81 million patients mostly in the USA). Using a retrospective cohort study and time-to-event analysis, we compared the incidences of COVID-19 outcomes between individuals who received a COVID-19 vaccine (approved for use in the USA) at least 2 weeks before SARS-CoV-2 infection and propensity score-matched individuals unvaccinated for COVID-19 but who had received an influenza vaccine. Outcomes were ICD-10 codes representing documented COVID-19 sequelae in the 6 months after a confirmed SARS-CoV-2 infection (recorded between January 1 and August 31, 2021, i.e. before the emergence of the Omicron variant). Associations with the number of vaccine doses (1 vs. 2) and age (<60 vs. ≥ 60 years-old) were assessed. Among 10,024 vaccinated individuals with SARS-CoV-2 infection, 9479 were matched to unvaccinated controls. Receiving at least one COVID-19 vaccine dose was associated with a significantly lower risk of respiratory failure, ICU admission, intubation/ventilation, hypoxaemia, oxygen requirement, hypercoagulopathy/venous thromboembolism, seizures, psychotic disorder, and hair loss (each as composite endpoints with death to account for competing risks; HR 0.70-0.83, Bonferroni-corrected p < 0.05), but not other outcomes, including long-COVID features, renal disease, mood, anxiety, and sleep disorders. Receiving 2 vaccine doses was associated with lower risks for most outcomes. Associations between prior vaccination and outcomes of SARS-CoV-2 infection were marked in those <60 years-old, whereas no robust associations were observed in those ≥60 years-old. In summary, COVID-19 vaccination is associated with lower risk of several, but not all, COVID-19 sequelae in those with breakthrough SARS-CoV-2 infection. The findings may inform service planning, contribute to forecasting public health impacts of vaccination programmes, and highlight the need to identify additional interventions for COVID-19 sequelae.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2022.04.013

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 1×
“23 However, our results highlight that some post-acute outcomes of SARS-CoV-2 (and notably long-COVID presentations) are likely to persist even after successful vaccination of the population, so long as breakthrough infections occur.”
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189 · cited 2×
“The study used TriNetX Analytics, a federated network of linked EHRs recording anonymized data from 59 healthcare organizations (HCOs), primarily in the USA, totalling 81 million patients.”
Self-citation
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Haas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00947-8 · Cited by 1,564 · cited 1×
“Discussion 304 It is established that vaccination protects against hospitalisation, ICU admission, and death 305 from COVID-19 (Agrawal et al., 2021; Antonelli et al., 2021; Bahl et al., 2021; Butt et al., 306 2021; Cabezas et al., 2021; Glatman-Freedman et al., 2021; Haas et al., 2021; Hyams et al., 307 2021; Mateo-U…”
Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
Royston, P. J., & Parmar, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,537
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 1×
“We investigated the 6-month incidence of all acute and post-acute outcomes which have been shown to be significantly associated with COVID-19 in four large-scale studies based on electronic health records (Al-Aly et al., 2021; Daugherty et al., 2021; Taquet et al., 2021b, 2021a), namely:”
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.
Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Self-citation
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
Taquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 948
Self-citation
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., Graham, M. S., Klaser, K., Modat, M., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00460-6 · Cited by 843

Show all 37 references

Research works printed but not linked: 1

McEwen, 2021, Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State, Clin. Infect. Dis.

Sorted by citations

Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients
Taquet, M., Sillett, R., Zhu, L., Mendel, J., Camplisson, I., Dercon, Q., & Harrison, P. J. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00260-7 · Cited by 737
Self-citation
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review
Notarte, K. I., Catahay, J. A., Velasco, J. V., Pastrana, A., Ver, A. T., Pangilinan, F. C., Peligro, P. J., Casimiro, M., Guerrero, J. J., Gellaco, M. M. L., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101624 · Cited by 480
The immunology of long COVID
Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J., & Boyton, R. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00904-7 · Cited by 471
Effect of covid-19 vaccination on long covid: systematic review
Byambasuren, O., Stehlik, P., Clark, J. M., Alcorn, K., & Glasziou, P. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000385 · Cited by 340
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Mizrahi, B., Sudry, T., Flaks‐Manov, N., Yehezkelli, Y., Kalkstein, N., Akiva, P., Ekka-Zohar, A., David, S. S. B., Lerner, U., Bivas‐Benita, M., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072529 · Cited by 345
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
Watanabe, A., Iwagami, M., Yasuhara, J., Takagi, H., & Kuno, T. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.008 · Cited by 304
Long COVID: pathophysiological factors and abnormalities of coagulation
Turner, S., Khan, A., Putrino, D. F., Woodcock, A. A., Kell, D. B., & Pretorius, E. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.03.002 · Cited by 247
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
Kuodi, P., Gorelik, Y., Zayyad, H., Wertheim, O., Wiegler, K. B., Jabal, K. A., Dror, A. A., Nazzal, S., Glikman, D., & Edelstein, M. L. (2022) · npj Vaccines · doi:10.1038/s41541-022-00526-5 · Cited by 222
Long COVID: mechanisms, risk factors and recovery
Astin, R., Banerjee, A., Baker, M. R., Dani, M., Ford, E. M., Hull, J. H., Lim, P. B., McNarry, M. A., Morten, K., O’Sullivan, O., et al. (2022) · Experimental Physiology · doi:10.1113/ep090802 · Cited by 225
Self-citation
Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis
Gao, P., Liu, J., & Liu, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912422 · Cited by 205
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
Hastie, C. E., Lowe, D. J., McAuley, A., Winter, A., Mills, N. L., Black, C., Scott, J. T., O’Donnell, C. A., Blane, D., Browne, S. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33415-5 · Cited by 205
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study
Ayoubkhani, D., Bosworth, M. L., King, S., Pouwels, K. B., Glickman, M., Nafilyan, V., Zaccardi, F., Khunti, K., Alwan, N. A., & Walker, A. S. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac464 · Cited by 205
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
Català, M., Mercadé‐Besora, N., Kolde, R., Trinh, N. T., Roel, E., Burn, E., Rathod‐Mistry, T., Kostka, K., Man, W. Y., Delmestri, A., et al. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00414-9 · Cited by 179
Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022
Kompaniyets, L., Bull–Otterson, L., Boehmer, T. K., Baca, S., Alvarez, P., Hong, K., Hsu, J., Harris, A. M., Gundlapalli, A. V., & Saydah, S. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7131a3 · Cited by 161
The recombinant shingles vaccine is associated with lower risk of dementia
Taquet, M., Dercon, Q., Todd, J. A., & Harrison, P. J. (2024) · Nature Medicine · doi:10.1038/s41591-024-03201-5 · Cited by 159
Self-citation
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Li, J., Zhou, Y., Ma, J., Zhang, Q., Shao, J., Liang, S., Yu, Y., Li, W., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01640-z · Cited by 150
Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program
Brannock, M. D., Chew, R., Preiss, A., Hadley, E., Redfield, S., McMurry, J. A., Leese, P., Girvin, A. T., Crosskey, M., Zhou, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38388-7 · Cited by 138
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
Ceban, F., Kulzhabayeva, D., Rodrigues, N. B., Vincenzo, J. D. D., Gill, H., Subramaniapillai, M., Lui, L. M. W., Cao, B., Mansur, R. B., Ho, R., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.022 · Cited by 137
Post‐COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross‐sectional evaluation from a community COVID rehabilitation service
Sivan, M., Parkin, A., Makower, S., & Greenwood, D. C. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27456 · Cited by 137
Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study
Lundberg, L., Leach, S., Xu, Y., Martikainen, J., Santosa, A., Gisslén, M., Li, H., Nyberg, F., & Bygdell, M. (2023) · BMJ · doi:10.1136/bmj-2023-076990 · Cited by 110
Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System
Ioannou, G. N., Baraff, A. J., Fox, A., Shahoumian, T. A., Hickok, A. W., O’Hare, A. M., Bohnert, A. S. B., Boyko, E. J., Maciejewski, M. L., Bowling, C. B., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.24359 · Cited by 99
COVID-19 Outcomes and Risk Factors Among People Living with HIV
Spinelli, M. A., Jones, B. L. H., & Gandhi, M. (2022) · Current HIV/AIDS Reports · doi:10.1007/s11904-022-00618-w · Cited by 106
Epidemiological and clinical perspectives of long COVID syndrome
Huerne, K., Filion, K. B., Grad, R. M., Ernst, P., Gershon, A. S., & Eisenberg, M. J. (2023) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2023.100033 · Cited by 110
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
Taquet, M., Skórniewska, Z., Hampshire, A., Chalmers, J. D., Ho, L., Horsley, A. R., Marks, M., Poinasamy, K., Raman, B., Leavy, O. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02525-y · Cited by 94
Self-citation
A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China
Cai, J., Lin, K., Zhang, H., Xue, Q., Zhu, K., Yuan, G., Sun, Y., Zhu, F., Ai, J., Wang, S., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2220578 · Cited by 85
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
Marra, A. R., Kobayashi, T., Callado, G. Y., Pardo, I., Gutfreund, M. C., Hsieh, M. K., Lin, V., Alsuhaibani, M., Hasegawa, S., Tholany, J., et al. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2023.447 · Cited by 83
Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post‐acute sequelae of SARS‐CoV ‐2 infection ( PASC )
Blitshteyn, S., Whiteson, J. H., Abramoff, B. A., Azola, A. M., Bartels, M. N., Bhavaraju-Sanka, R. K., Chung, T., Fleming, T. K., Henning, E., Miglis, M. G., et al. (2022) · PM&R · doi:10.1002/pmrj.12894 · Cited by 79
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
Boufidou, F., Medić, S., Lampropoulou, V., Siafakas, N., Tsakris, A., & Anastassopoulou, C. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612962 · Cited by 85
Post-COVID syndrome
Hallek, M. J., Adorjan, K., Behrends, U., Ertl, G., Suttorp, N., & Lehmann, C. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0409 · Cited by 92
Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK
Taquet, M., Skórniewska, Z., Deyn, T. D., Hampshire, A., Trender, W. R., Hellyer, P. J., Chalmers, J. D., Horsley, A. R., Horsley, A. R., Marks, M., et al. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00214-1 · Cited by 77
Self-citation
The Effect of SARS-CoV-2 Vaccination on Post-Acute COVID-19 Syndrome (PACS): A Prospective Cohort Study
Wynberg, E., Han, A. X., Boyd, A. C., van Willigen, H. D. G., Verveen, A., Lebbink, R., van der Straten, K., Kootstra, N. A., van Gils, M. J., Russell, C. A., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.05.090 · Cited by 74
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Jing, H., Wu, X., Xiang, M., Liu, L., Novakovic, V. A., & Shi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.992384 · Cited by 81
Evolution of neurologic symptoms in non‐hospitalized COVID ‐19 “long haulers”
Ali, S. T., Kang, A. K., Patel, T. R., Clark, J. R., Perez-Giraldo, G., Orban, Z. S., Lim, P. H., Jimenez, M., Graham, E. L., Batra, A., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51570 · Cited by 70
Do vaccines protect against long COVID? What the data say
Ledford, H. K. (2021) · Nature · doi:10.1038/d41586-021-03495-2 · Cited by 68
Pathophysiological, immunological, and inflammatory features of long COVID
Böhmwald, K., Diethelm‐Varela, B., Rodríguez‐Guilarte, L., Rivera, T., Riedel, C. A., González, P. A., & Kalergis, A. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341600 · Cited by 80
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
Ozonoff, A., Schaenman, J. M. D., Jayavelu, N. D., Milliren, C. E., Calfee, C. S., Cairns, C. B., Kraft, M., Baden, L. R., Shaw, A. C., Krammer, F., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104208 · Cited by 65
Vaccine Effectiveness Against Long COVID in Children
Razzaghi, H., Forrest, C. B., Hirabayashi, K., Wu, Q., Allen, A. J., Rao, S., Chen, Y., Bunnell, H. T., Chrischilles, E. A., Cowell, L. G., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2023-064446 · Cited by 74
Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
Diexer, S., Klee, B., Gottschick, C., Xu, C., Broda, A., Purschke, O., Binder, M., Frese, T., Girndt, M., Hoell, J. I., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.08.019 · Cited by 66
Neurological post‐acute sequelae of SARS‐CoV ‐2 infection
Takao, M., & Ohira, M. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13481 · Cited by 66
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
Peghin, M., Martino, M. D., Palese, A., Gerussi, V., Bontempo, G., Graziano, E., Visintini, E., D’Elia, D., Dellai, F., Marrella, F., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.03.016 · Cited by 60
COVID-19 Vaccine and Long COVID: A Scoping Review
Mumtaz, A., Sheikh, A. A. E., Khan, A. M., Khalid, S. N., Khan, J., Nasrullah, A., Sagheer, S., & Sheikh, A. B. (2022) · Life · doi:10.3390/life12071066 · Cited by 62
Long covid in children and adolescents
Zimmermann, P., Pittet, L. F., & Curtis, N. C. (2022) · BMJ · doi:10.1136/bmj.o143 · Cited by 58
Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts
Ballouz, T., Menges, D., Kaufmann, M., Amati, R., Frei, A. L., von Wyl, V., Fehr, J. S., Albanese, E., & Puhan, M. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281429 · Cited by 55
Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity
Fischer, A., Zhang, L., Elbéji, A., Wilmes, P., Oustric, P., Staub, T., Nazarov, P. V., Ollert, M. W., & Fagherazzi, G. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac397 · Cited by 57
Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status
Yu, E. D., Wang, E. W., Garrigan, E., Goodwin, B., Sutherland, A., Tarke, A., Chang, J., Gálvez, R. I., Mateus, J., Ramirez, S. I., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.003 · Cited by 45
Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection
Hanson, B. A., Visvabharathy, L., Orban, Z. S., Jimenez, M., Batra, A., Liotta, E. M., DeLisle, R. K., Klausner, J. D., Cohen, P., Padhye, A. S., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.022 · Cited by 40
The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis
Marra, A. R., Kobayashi, T., Suzuki, H., Alsuhaibani, M., Hasegawa, S., Tholany, J., Perencevich, E. N., Maezato, A. M., Ricardo, V. C. V., Salinas, J. L., et al. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.336 · Cited by 37
The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysis
Chow, K. N., Tsang, Y. W., Chan, Y. H., Telaga, S. A., Ng, L. Y. A., Chung, C. M., Yip, Y. M., & Cheung, P. P. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106358 · Cited by 49
Long COVID: what is known and what gaps need to be addressed
Krishna, B. A., Wills, M. R., & Sithole, N. (2023) · British Medical Bulletin · doi:10.1093/bmb/ldad016 · Cited by 40
A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination
Hamdh, B. A., & Nazzal, Z. A. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-30583-2 · Cited by 36
Divergent adaptive immune responses define two types of long COVID
Kervevan, J., Staropoli, I., Slama, D., Jeger‐Madiot, R., Donnadieu, F., Planas, D., Pietri, M. P., Loghmari-Bouchneb, W., Tanah, M. A., Robinot, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1221961 · Cited by 35
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis
Man, M. A., Rosca, D., Bratosin, F., Firă-Mladinescu, O., Ilie, A. C., Burtic, S.-R., Fildan, A. P., Fizedean, C. M., Jianu, A. M., Negrean, R. A., et al. (2024) · Vaccines · doi:10.3390/vaccines12020189 · Cited by 35
Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections
Taquet, M., Todd, J. A., & Harrison, P. J. (2025) · npj Vaccines · doi:10.1038/s41541-025-01172-3 · Cited by 34
Self-citation
Neuropsychiatric disorders following SARS-CoV-2 infection
Harrison, P. J., & Taquet, M. (2023) · Brain · doi:10.1093/brain/awad008 · Cited by 34
Self-citation
Long-term risk of psychiatric disorder and psychotropic prescription after SARS-CoV-2 infection among UK general population
Wang, Y., Su, B., Xie, J., García‐Rizo, C., & Prieto‐Alhambra, D. (2024) · Nature Human Behaviour · doi:10.1038/s41562-024-01853-4 · Cited by 36
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection
Malden, D. E., Liu, I. A., Qian, L., Sy, L. S., Lewin, B. J., Asamura, D. T., Ryan, D. S., Bezi, C., Williams, J. T. B., Kaiser, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48022-9 · Cited by 32
The interplay of post-acute COVID-19 syndrome and aging: a biological, clinical and public health approach
Guaraldi, G., Milić, J., Cesari, M., Leibovici, L., Mandreoli, F., Missier, P., Rozzini, R., Cattelan, A. M., Motta, F., Mussini, C., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101686 · Cited by 33
Vaccination status and long COVID symptoms in patients discharged from hospital
Nascimento, T. C. D. C., Costa, L. D. V., Ruiz, A., Ledo, C. B., Fernandes, V. P. L., Cardoso, L. F., Vieira, J. M., Saretta, R., Filho, R. K., & Drager, L. F. (2023) · Scientific Reports · doi:10.1038/s41598-023-28839-y · Cited by 29
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Rzymski, P., Pokorska‐Śpiewak, M., Jackowska, T., Kuchar, E. P., Nitsch-Osuch, A. S., Pawłowska, M., Babicki, M., Jaroszewicz, J., Szenborn, L., Wysocki, J., et al. (2023) · Vaccines · doi:10.3390/vaccines11091502 · Cited by 31
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER ProgramPreprint
Brannock, M. D., Chew, R., Preiss, A., Hadley, E., McMurry, J. A., Leese, P., Girvin, A. T., Crosskey, M., Zhou, A., Moffitt, R. A., et al. (2022) · medRxiv · doi:10.1101/2022.10.06.22280795 · Cited by 31
Acute and long COVID-19 symptoms and associated factors in the omicron-dominant period: a nationwide survey via the online platform Wenjuanxing in China
Su, Z., Li, Y., Xie, Y., Huang, Z., Cheng, A., Zhou, X., Li, J., Qin, R., Wei, X., Liu, Y., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-19510-w · Cited by 33
Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis
Zhang, T., Li, Z., Mei, Q., Walline, J. H., Zhang, Z., Liu, Y., Zhu, H., & Du, B. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1450470 · Cited by 33
Persistent Symptoms After Acute COVID-19 Infection in Omicron Era
Jung, Y. H., Ha, E.-H., Choe, K. W., Lee, S., Jo, D. H., & Lee, W. J. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e213 · Cited by 28
Differences in Long-COVID Symptoms between Vaccinated and Non-Vaccinated (BNT162b2 Vaccine) Hospitalized COVID-19 Survivors Infected with the Delta Variant
Fernández‐de‐las‐Peñas, C., Ortega‐Santiago, R., Fuensalida‐Novo, S., Martín‐Guerrero, J. D., Pellicer-Valero, Ó. J., & Torres‐Macho, J. (2022) · Vaccines · doi:10.3390/vaccines10091481 · Cited by 27
Risk factors and preventive interventions for post Covid-19 condition: systematic review
Pillay, J., Rahman, S., Guitard, S., Wingert, A., & Hartling, L. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2140612 · Cited by 30
Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection
Wee, L. E., Lim, J. T., Tay, A. T., Pang, D., Dickens, B. S. L., Chiew, C. J., Ong, B. K. C., Lye, D. C., & Tan, K. B. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.12.019 · Cited by 27
Natural course of post-COVID symptoms in adults and children
Sugiyama, A., Takafuta, T., Sato, T., Kitahara, Y., Yoshinaga, Y., Abe, K., Chhoung, C., Akuffo, G. A., Phyo, Z., Kurisu, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54397-y · Cited by 27
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents
Wu, Q., Zhang, B., Tong, J., Bailey, L. C., Bunnell, H. T., Chen, J., Chrischilles, E. A., Christakis, D., Downs, S. M., Hirabayashi, K., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102962 · Cited by 25
Association between long COVID and vaccination: A 12-month follow-up study in a low- to middle-income country
Fatima, S., Ismail, M., Ejaz, T., Shah, Z. A., Fatima, S., Shahzaib, M., & Jafri, H. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294780 · Cited by 25
Long COVID management: a mini review of current recommendations and underutilized modalities
Dietz, T. K., & Brondstater, K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1430444 · Cited by 25
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
Brunvoll, S. H., Nygaard, A. B., Fagerland, M. W., Holland, P., Ellingjord‐Dale, M., Dahl, J. A., & Søraas, A. V. L. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.009 · Cited by 25
Behavioral ecology of primate-parasite interactions
Wren, B. T. (2013) · Purdue e-Pubs (Purdue University System) · Cited by 25
Long COVID: A growing problem in need of intervention
Blomberg, B., Cox, R. J., & Langeland, N. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100552 · Cited by 23
Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study
Tisler, A., Stirrup, O., Pisarev, H., Kalda, R., Meister, T., Suija, K., Kolde, R., Piirsoo, M., & Uusküla, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278057 · Cited by 23
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
Henderson, A. D., Butler-Cole, B. F. C., Tazare, J., Tomlinson, L. A., Marks, M., Jit, M., Briggs, A. H., Lin, L.-Y., Carlile, O., Bates, C. J., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102638 · Cited by 30
Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights
Lenz, C., Slack, M., Shea, K. M., Reinert, R. R., Taysi, B. N., & Swerdlow, D. L. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2190405 · Cited by 28
How does COVID-19 vaccination affect long-COVID symptoms?
Asadi‐Pooya, A. A., Nemati, M., Shahisavandi, M., Nemati, H., Karimi, A., Jafari, A., Nasiri, S., Mohammadi, S. S., Rahimian, Z., Bayat, H., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296680 · Cited by 27
High Prevalence of Long-COVID Among Kidney Transplant Recipients: A Longitudinal Cohort Study
Amorim, C. E. N., Lafico, V., Cristelli, M. P., Viana, L. A., Corrêa, H. D. L., Lima, G. B. B., Silva, F. S. D. S., Lima, G. S. D. C. E., Rosa, T. D. S., Nakamura, M. R., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004359 · Cited by 23
Impairments following COVID-19 infection: manifestations and investigations of related factors
Badinlou, F., Forsström, D., Jansson‐Fröjmark, M., Abzhandadze, T., & Lundgren, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-33810-y · Cited by 21
Retrospective Cohort Study of the Effectiveness of the Sputnik V and EpiVacCorona Vaccines against the SARS-CoV-2 Delta Variant in Moscow (June–July 2021)
Matveeva, O. V., & Ershov, A. (2022) · Vaccines · doi:10.3390/vaccines10070984 · Cited by 19
Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults
Maier, H. E., Kowalski-Dobson, T., Eckard, A., Gherasim, C., Manthei, D. M., Meyers, A., Davis, D., Bakker, K. M., Lindsey, K., Chu, Z., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae039 · Cited by 21
COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records
Hsieh, T. Y. J., Chang, R., Yong, S., Liao, P., Hung, Y., & Wei, J. C. (2023) · Diabetes Care · doi:10.2337/dc23-0936 · Cited by 19
The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022
MacCallum‐Bridges, C. L., Hirschtick, J. L., Patel, A. J., Orellana, R. C., Elliott, M. R., & Fleischer, N. L. (2024) · Annals of Epidemiology · doi:10.1016/j.annepidem.2024.02.007 · Cited by 18
Substantial health and economic burden of COVID-19 during the year after acute illness among US adults not at high risk of severe COVID-19
Scott, A., Ansari, W., Chambers, R. B., Reimbaeva, M., Mikolajczyk, T. P., Benigno, M., Draica, F., & Atkinson, J. (2024) · BMC Medicine · doi:10.1186/s12916-023-03235-5 · Cited by 15
Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causes
Ley, H., Skórniewska, Z., Harrison, P. J., & Taquet, M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.05.014 · Cited by 17
Self-citation
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
Kontoghiorghes, G. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126735 · Cited by 16
Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up
Babicki, M., Kapusta, J., Pieniawska‐Śmiech, K., Kałuzińska‐Kołat, Ż., Kołat, D., Mastalerz–Migas, A., Jankowski, P., & Chudzik, M. (2023) · Viruses · doi:10.3390/v15061370 · Cited by 19
Sleep quality and sleep patterns among recovered individuals during post-COVID-19 among Jordanian: A cross-sectional national study
Abuhammad, S., Alzoubi, K. H., Khabour, O. F., Hamaideh, S. H., & Khassawneh, B. Y. (2023) · Medicine · doi:10.1097/md.0000000000032737 · Cited by 15
Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022)
Domènech-Montoliu, S., Puig‐Barberà, J., Badenes-Marques, G., Gil, M., Orrico‐Sánchez, A., Pac-Sa, M. R., Pérez-Olaso, Ó., Sala-Trull, D., Sanchéz-Urbano, M., & Arnedo-Pena, A. (2023) · Vaccines · doi:10.3390/vaccines11101590 · Cited by 15
Vaccination prior to SARS-CoV-2 infection does not affect the neurologic manifestations of long COVID
Mukherjee, S., Singer, T., Venkatesh, A., Choudhury, N. A., Perez-Giraldo, G., Jimenez, M., Miller, J. L., Lopez, M., Hanson, B. A., Bawa, A. P., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae448 · Cited by 17
SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?
Luo, E. Y., Chang, R. C., & Gilbert‐Jaramillo, J. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100888 · Cited by 14
European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19
Crook, H., Ramírez, A., Hosseini, A. A., Vavougios, G. D., Lehmann, C., Bruchfeld, J., Schneider, A., d’Avossa, G., Re, V. L., Salmoiraghi, A., et al. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0058 · Cited by 12
A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition
Jennings, S., Corrin, T., & Waddell, L. A. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823001279 · Cited by 12
Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions
He, S., Wu, K., Cheng, Z., He, M., Hu, R., Fan, N., Shen, L., Li, Q., Fan, H., & Tong, Y. (2022) · MedComm · doi:10.1002/mco2.196 · Cited by 11
Prevalence, Patterns, and Clinical Severity of Long COVID among Chinese Medicine Telemedicine Service Users: Preliminary Results from a Cross-Sectional Study
Ho, F. F., Xu, S., Kwong, T. M. H., Li, A. S., Ha, E. H., Hua, H.-Y., Liong, C., Leung, K. C., Leung, T. H., Lin, Z., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031827 · Cited by 13
Myocarditis and Myocardial Injury in Long COVID Syndrome: A Comprehensive Review of the Literature
Paruchuri, S. S. H., Farwa, U. E., Jabeen, S., Pamecha, S., Shan, Z., Parekh, R., Lakkimsetti, M., Alamin, E., Sharma, V., Haider, S., et al. (2023) · Cureus · doi:10.7759/cureus.42444 · Cited by 12
CALMS: Modelling the long-term health and economic impact of Covid-19 using agent-based simulation
Mintram, K. S., Anagnostou, A., Anokye, N., Okine, E., Groen, D., Saha, A., Abubakar, N. T., Islam, T., Daroge, H., Ghorbani, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272664 · Cited by 13
A Case-Crossover Phenome-wide association study (PheWAS) for understanding Post-COVID-19 diagnosis patterns
Haupert, S. R., Shi, X., Chen, C., Fritsche, L. G., & Mukherjee, B. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104237 · Cited by 10
Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV
Wang, Y., Li, J., Zhang, W., Liu, S., Miao, L., Li, Z., Fu, A., Bao, J., Huang, L., Zheng, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152695 · Cited by 11

Authors: Taquet, M., Dercon, Q., & Harrison, P. J.
Affiliations: Oxford Health NHS Foundation Trust (GB)
MRC Cognition and Brain Sciences Unit (GB)
Corresponding author: Taquet, Maxime
ORCID: Taquet, Maxime
Dercon, Quentin
Harrison, Paul J.
Venue: Brain, Behavior, and Immunity
Publisher: Elsevier BV
Published: 2022-07
Volume: 103
Pages: 154-162
ISSN: 0889-1591 (ISSN-L)
DOI: 10.1016/j.bbi.2022.04.013
PMC: PMC9013695
OpenAlex: W4225562523
Cited by: 246
References: 37
Citations by year: 2026: 8 · 2025: 28 · 2024: 68 · 2023: 79 · 2022: 60
FWCI: 28.72
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Brain Behavior and Immunity (publishedVersion, cc-by)
medRxiv (acceptedVersion, cc-by-nc)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Apollo (University of Cambridge) (submittedVersion)
Apollo
Funders: National Institute for Health and Care Research
AXA Research Fund (G102329)
NIHR Oxford Biomedical Research Centre (BRC-1215-20005)
Medical Research Council (SUAG/077 G101400)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Keywords: breakthrough infection, SARS-CoV-2, post-COVID-19 sequelae, long COVID, respiratory failure, intensive care unit admission, intubation and mechanical ventilation, hypoxemia, venous thromboembolism, hypercoagulability, seizures, psychosis, hair loss, vaccine dose number, older adults, Omicron variant
MeSH terms: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Post-Acute COVID-19 Syndrome, Humans, Middle Aged, Retrospective Studies, Vaccination, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks